| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adeno-associated virus–based gene therapy for hemophilia A and B: a systematic review and meta-analysis
|
Deshpande, Saarang R.
|
|
|
8 |
23 |
p. 5957-5974
|
artikel
|
| 2 |
Ancestral β-globin gene haplotypes modify β-thalassemia severity in a mouse model
|
Lechauve, Christophe
|
|
|
8 |
23 |
p. 5988-5992
|
artikel
|
| 3 |
Charting the course for CAR T-cell manufacturing
|
Elsallab, Magdi
|
|
|
8 |
23 |
p. 6131-6132
|
artikel
|
| 4 |
CYB5R3 T117S tempers fetal hemoglobin induction by hydroxyurea in patients with sickle cell disease
|
Chowdhury, Fabliha A.
|
|
|
8 |
23 |
p. 6098-6103
|
artikel
|
| 5 |
Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19–depleted pediatric haploidentical HCT for hematologic malignancy
|
Dvorak, Christopher C.
|
|
|
8 |
23 |
p. 6003-6014
|
artikel
|
| 6 |
Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis
|
Abdallah, Maya
|
|
|
8 |
23 |
p. 5935-5938
|
artikel
|
| 7 |
Gene therapy for hemophilia
|
Lenting, Peter J.
|
|
|
8 |
23 |
p. 6081
|
artikel
|
| 8 |
Guidelines are needed to advance health equity in hematology
|
Fingrut, Warren B.
|
|
|
8 |
23 |
p. 6127-6128
|
artikel
|
| 9 |
Immune reconstitution and evolution of B-cell–stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL
|
Liévin, Raphaël
|
|
|
8 |
23 |
p. 6017-6027
|
artikel
|
| 10 |
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
|
Aldoss, Ibrahim
|
|
|
8 |
23 |
p. 6139-6147
|
artikel
|
| 11 |
Impact of prior treatment on CAR T-cell outcome in adult ALL
|
Marks, David I.
|
|
|
8 |
23 |
p. 6137-6138
|
artikel
|
| 12 |
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease
|
John, Tami D.
|
|
|
8 |
23 |
p. 6055-6063
|
artikel
|
| 13 |
Iron deficiency resolution and time to resolution in an American health system
|
Cogan, Jacob C.
|
|
|
8 |
23 |
p. 6029-6034
|
artikel
|
| 14 |
Lezina L, Spriggs RV, Beck D, et al. CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM. Blood Adv. 2018;2(15):1869-1881.
|
|
|
|
8 |
23 |
p. 6028
|
artikel
|
| 15 |
Management of iron deficiency in women in Scotland
|
MacLean, Beth
|
|
|
8 |
23 |
p. 6129-6130
|
artikel
|
| 16 |
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
|
Rücker, Frank G.
|
|
|
8 |
23 |
p. 6067-6080
|
artikel
|
| 17 |
Mitani K, Lee JW, Jang JH, et al. Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study. Blood Adv. 2024;8(6):1415-1419.
|
|
|
|
8 |
23 |
p. 6097
|
artikel
|
| 18 |
Model-based dosing for better survival after transplantation
|
Boelens, Jaap Jan
|
|
|
8 |
23 |
p. 6064-6066
|
artikel
|
| 19 |
Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia
|
Vijenthira, Abi
|
|
|
8 |
23 |
p. 5949-5956
|
artikel
|
| 20 |
Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes
|
Spellman, Stephen R.
|
|
|
8 |
23 |
p. 6082-6087
|
artikel
|
| 21 |
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany
|
Arslan, Aysenur
|
|
|
8 |
23 |
p. 6104-6113
|
artikel
|
| 22 |
OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL
|
Linhares, Yuliya
|
|
|
8 |
23 |
p. 6114-6126
|
artikel
|
| 23 |
Peripheral human red blood cell development in human immune system mouse model with heme oxygenase-1 deficiency
|
Patel, Aditi Khatri
|
|
|
8 |
23 |
p. 5975-5987
|
artikel
|
| 24 |
Point-of-care CAR T manufacturing solutions: can 1 model fit all?
|
Urbano-Ispizua, Álvaro
|
|
|
8 |
23 |
p. 6133-6136
|
artikel
|
| 25 |
Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis
|
Ebraheem, Mohammad S.
|
|
|
8 |
23 |
p. 5993-6002
|
artikel
|
| 26 |
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis
|
Venkat, Rathnam K.
|
|
|
8 |
23 |
p. 6043-6054
|
artikel
|
| 27 |
Social determinants of health affect disease severity among preschool children with sickle cell disease
|
Khan, Hamda
|
|
|
8 |
23 |
p. 6088-6096
|
artikel
|
| 28 |
The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL
|
Wichert, Maren Christiane
|
|
|
8 |
23 |
p. 6035-6042
|
artikel
|
| 29 |
The duration of iron deficiency burden
|
MacLean, Beth
|
|
|
8 |
23 |
p. 6148-6149
|
artikel
|
| 30 |
The promises and potential pitfalls of pharmacokinetic model–based dosing in cellular therapy
|
Scordo, Michael
|
|
|
8 |
23 |
p. 6015-6016
|
artikel
|
| 31 |
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature
|
Bommier, Côme
|
|
|
8 |
23 |
p. 5939-5948
|
artikel
|
Tijdschrift beschrijving